1
|
Arribas-Arribas B, Fernández-Muñoz B, Campos-Cuerva R, Montiel-Aguilera MÁ, Bermejo-González M, Lomas-Romero I, Martín-López M, Alcázar-Caballero RM, Del Mar Macías-Sánchez M, Campos F, Alaminos M, Gómez-Cía T, Gacto P, Carmona G, Santos-González M. Nanostructured fibrin-agarose hydrogels loaded with allogeneic fibroblasts as bio-dressings for acute treatment of massive burns. Biomed Pharmacother 2023; 168:115769. [PMID: 39491860 DOI: 10.1016/j.biopha.2023.115769] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2023] [Revised: 10/15/2023] [Accepted: 10/18/2023] [Indexed: 11/05/2024] Open
Abstract
The prompt management of patients with massive burns is essential to maximize survival by preventing infection, hemorrhage, fluid and heat loss, and to optimally prepare the wound bed for the application of autografts or cultured tissue-engineered artificial autologous skin. Acute treatments are typically based on temporary bio-dressings, commonly cadaveric skin allografts, but supply challenges, high costs and increasingly stringent regulatory requirements preclude their widespread use. Nanostructured fibrin-agarose hydrogels (NFAH) have been proven to be safe and effective biomaterials in preclinical and clinical studies, and show good hemostatic and biomechanical properties. Here we generated and tested NFAH with embedded allogeneic dermal fibroblasts (NFAH-F) under Good Manufacturing Practice (GMP) conditions. Fibroblasts were first expanded and characterized to create a GMP bank and the NFAH-F was manufactured on demand. Three patients with major burns were treated with this product as a temporary bio-dressing under compassionate use. Our results suggest that NFAH-F product was a safe product and no adverse reactions were observed. In all cases, the patients survived until definitive treatment. Therefore, the application of NFAH-F might be a temporary bio-dressing for patients with massive burns when cadaveric skin allografts are not available.
Collapse
Affiliation(s)
- Blanca Arribas-Arribas
- Unidad de Producción y Reprogramación Celular de Sevilla (UPRC), Red Andaluza de diseño y traslación de Terapias Avanzadas (RAdytTA), Fundación Pública Andaluza Progreso y Salud, Seville, Spain; Centro de Transfusión, Tejidos y Células (CTTC) de Sevilla, Seville, Spain; Programa doctorado Tecnología y Ciencias del Medicamento, Facultad de Farmacia, Universidad de Sevilla, Seville, Spain.
| | - Beatriz Fernández-Muñoz
- Unidad de Producción y Reprogramación Celular de Sevilla (UPRC), Red Andaluza de diseño y traslación de Terapias Avanzadas (RAdytTA), Fundación Pública Andaluza Progreso y Salud, Seville, Spain
| | - Rafael Campos-Cuerva
- Unidad de Producción y Reprogramación Celular de Sevilla (UPRC), Red Andaluza de diseño y traslación de Terapias Avanzadas (RAdytTA), Fundación Pública Andaluza Progreso y Salud, Seville, Spain
| | - Miguel Ángel Montiel-Aguilera
- Unidad de Producción y Reprogramación Celular de Sevilla (UPRC), Red Andaluza de diseño y traslación de Terapias Avanzadas (RAdytTA), Fundación Pública Andaluza Progreso y Salud, Seville, Spain; Centro de Transfusión, Tejidos y Células (CTTC) de Sevilla, Seville, Spain
| | - María Bermejo-González
- Unidad de Producción y Reprogramación Celular de Sevilla (UPRC), Red Andaluza de diseño y traslación de Terapias Avanzadas (RAdytTA), Fundación Pública Andaluza Progreso y Salud, Seville, Spain; Centro de Transfusión, Tejidos y Células (CTTC) de Sevilla, Seville, Spain
| | - Isabel Lomas-Romero
- Unidad de Producción y Reprogramación Celular de Sevilla (UPRC), Red Andaluza de diseño y traslación de Terapias Avanzadas (RAdytTA), Fundación Pública Andaluza Progreso y Salud, Seville, Spain
| | - María Martín-López
- Unidad de Producción y Reprogramación Celular de Sevilla (UPRC), Red Andaluza de diseño y traslación de Terapias Avanzadas (RAdytTA), Fundación Pública Andaluza Progreso y Salud, Seville, Spain; Instituto de Investigaciones Biomédicas de Sevilla (IBIS), Seville, Spain
| | - Rosario Mata Alcázar-Caballero
- Red Andaluza de diseño y traslación de Terapias Avanzadas-RAdytTA, Fundación Pública Andaluza Progreso y Salud-FPS, Seville, Spain
| | - María Del Mar Macías-Sánchez
- Red Andaluza de diseño y traslación de Terapias Avanzadas-RAdytTA, Fundación Pública Andaluza Progreso y Salud-FPS, Seville, Spain
| | - Fernando Campos
- Tissue Engineering Group. Facultad de Medicina, Universidad de Granada, Granada, Spain and Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
| | - Miguel Alaminos
- Tissue Engineering Group. Facultad de Medicina, Universidad de Granada, Granada, Spain and Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
| | - Tomás Gómez-Cía
- Unidad de Gestión Clínica de Cirugía Plástica y Grandes Quemados, Hospital Universitario Virgen del Rocío, Seville, Spain
| | - Purificación Gacto
- Unidad de Gestión Clínica de Cirugía Plástica y Grandes Quemados, Hospital Universitario Virgen del Rocío, Seville, Spain
| | - Gloria Carmona
- Unidad de Producción y Reprogramación Celular de Sevilla (UPRC), Red Andaluza de diseño y traslación de Terapias Avanzadas (RAdytTA), Fundación Pública Andaluza Progreso y Salud, Seville, Spain; PhD program in Biomedicine, University of Granada, Spain
| | - Mónica Santos-González
- Unidad de Producción y Reprogramación Celular de Sevilla (UPRC), Red Andaluza de diseño y traslación de Terapias Avanzadas (RAdytTA), Fundación Pública Andaluza Progreso y Salud, Seville, Spain; Centro de Transfusión, Tejidos y Células (CTTC) de Sevilla, Seville, Spain.
| |
Collapse
|
2
|
Blanco-Elices C, Oruezabal RI, Sánchez-Porras D, Chato-Astrain J, Campos F, Alaminos M, Garzón I, Campos A. A novel 3D biofabrication strategy to improve cell proliferation and differentiation of human Wharton's jelly mesenchymal stromal cells for cell therapy and tissue engineering. Front Bioeng Biotechnol 2023; 11:1235161. [PMID: 37636000 PMCID: PMC10448765 DOI: 10.3389/fbioe.2023.1235161] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Accepted: 08/04/2023] [Indexed: 08/29/2023] Open
Abstract
Purpose: Obtaining sufficient numbers of cells in a short time is a major goal of cell culturing in cell therapy and tissue engineering. However, current bidimensional (2D) culture methods are associated to several limitations, including low efficiency and the loss of key cell differentiation markers on cultured cells. Methods: In the present work, we have designed a novel biofabrication method based on a three-dimensional (3D) culture system (FIBRIAGAR-3D). Human Wharton's jelly mesenchymal stromal cells (HWJSC) were cultured in 3D using 100%, 75%, 50%, and 25% concentrations of fibrin-agarose biomaterials (FA100, FA75, FA50 and FA25 group) and compared with control cells cultured using classical 2D systems (CTR-2D). Results: Our results showed a significant increase in the number of cells generated after 7 days of culture, with cells displaying numerous expansions towards the biomaterial, and a significant overexpression of the cell proliferation marker KI67 was found for the FA75 and FA100 groups. TUNEL and qRT-PCR analyses demonstrated that the use of FIBRIAGAR-3D was not associated with an induction of apoptosis by cultured cells. Instead, the 3D system retained the expression of typical phenotypic markers of HWJSC, including CD73, CD90, CD105, NANOG and OCT4, and biosynthesis markers such as types-I and IV collagens, with significant increase of some of these markers, especially in the FA100 group. Finally, our analysis of 8 cell signaling molecules revealed a significant decrease of GM-CSF, IFN-g, IL2, IL4, IL6, IL8, and TNFα, suggesting that the 3D culture system did not induce the expression of pro-inflammatory molecules. Conclusion: These results confirm the usefulness of FIBRIAGAR-3D culture systems to increase cell proliferation without altering cell phenotype of immunogenicity and opens the door to the possibility of using this novel biofabrication method in cell therapy and tissue engineering of the human cornea, oral mucosa, skin, urethra, among other structures.
Collapse
Affiliation(s)
- Cristina Blanco-Elices
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
| | | | - David Sánchez-Porras
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
| | - Jesús Chato-Astrain
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
| | - Fernando Campos
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
| | - Miguel Alaminos
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
| | - Ingrid Garzón
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
| | - Antonio Campos
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, Universidad de Granada, Granada, Spain
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain
| |
Collapse
|
3
|
Fernández-Gómez P, Pérez de la Lastra Aranda C, Tosat-Bitrián C, Bueso de Barrio JA, Thompson S, Sot B, Salas G, Somoza Á, Espinosa A, Castellanos M, Palomo V. Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale. Front Bioeng Biotechnol 2023; 11:1191327. [PMID: 37545884 PMCID: PMC10401050 DOI: 10.3389/fbioe.2023.1191327] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Accepted: 05/23/2023] [Indexed: 08/08/2023] Open
Abstract
The new and unique possibilities that nanomaterials offer have greatly impacted biomedicine, from the treatment and diagnosis of diseases, to the specific and optimized delivery of therapeutic agents. Technological advances in the synthesis, characterization, standardization, and therapeutic performance of nanoparticles have enabled the approval of several nanomedicines and novel applications. Discoveries continue to rise exponentially in all disease areas, from cancer to neurodegenerative diseases. In Spain, there is a substantial net of researchers involved in the development of nanodiagnostics and nanomedicines. In this review, we summarize the state of the art of nanotechnology, focusing on nanoparticles, for the treatment of diseases in Spain (2017-2022), and give a perspective on the future trends and direction that nanomedicine research is taking.
Collapse
Affiliation(s)
- Paula Fernández-Gómez
- Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain
| | - Carmen Pérez de la Lastra Aranda
- Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain
- Centro de Investigaciones Biológicas Margarita Salas-CSIC, Madrid, Spain
| | - Carlota Tosat-Bitrián
- Centro de Investigaciones Biológicas Margarita Salas-CSIC, Madrid, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain
| | | | - Sebastián Thompson
- Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain
| | - Begoña Sot
- Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain
- Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Unidad de Innovación Biomédica, Madrid, Spain
- Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJ UAM), Madrid, Spain
| | - Gorka Salas
- Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain
- Unidad Asociada al Centro Nacional de Biotecnología (CSIC), Madrid, Spain
| | - Álvaro Somoza
- Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain
- Unidad Asociada al Centro Nacional de Biotecnología (CSIC), Madrid, Spain
| | - Ana Espinosa
- Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain
- Instituto de Ciencia de Materiales de Madrid, ICMM-CSIC, Madrid, Spain
| | - Milagros Castellanos
- Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain
| | - Valle Palomo
- Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain
- Unidad Asociada al Centro Nacional de Biotecnología (CSIC), Madrid, Spain
| |
Collapse
|
4
|
Ortiz-Arrabal O, Bermejo-Casares F, Garzón I, Mesa-García MD, Gómez-Llorente C, Alaminos M. Optimization of human skin keratinocyte culture protocols using bioactive molecules derived from olive oil. Biomed Pharmacother 2023; 164:115000. [PMID: 37301136 DOI: 10.1016/j.biopha.2023.115000] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2023] [Revised: 05/26/2023] [Accepted: 06/07/2023] [Indexed: 06/12/2023] Open
Abstract
Skin damage due to severe burns can compromise patient life. Current tissue engineering methods allow the generation of human skin substitutes for clinical use. However, this process is time-consuming, as the keratinocytes required to generate artificial skin have a low proliferation rate in culture. In this study, we evaluated the pro-proliferative effects of three natural biomolecules isolated from olive oil: phenolic extract (PE), DL-3,4-dihydroxyphenyl glycol (DHFG), and oleuropein (OLP), on cultured human skin keratinocytes. The results showed that PE and OLP increased the proliferation of immortalized human skin keratinocytes, especially at concentrations of 10 and 5 µg/mL, respectively, without altering cell viability. In contrast, DHFG did not produce a significant improvement in keratinocyte proliferation. In normal human skin keratinocytes obtained from skin biopsies, we found that PE, but not OLP, could increase the number of keratinocyte colonies and the area occupied by these cells. Furthermore, this effect was associated with increased KI-67 and Proliferating cell nuclear antigen (PCNA) gene expression. Thus, we propose that PE positively affects keratinocyte proliferation and could be used in culture protocols to improve bioartificial skin generation by tissue engineering.
Collapse
Affiliation(s)
- Olimpia Ortiz-Arrabal
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada E18016, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada E18012, Spain; Doctoral Program in Biochemistry and Molecular Biology, University of Granada, Granada E18071, Spain
| | - Fabiola Bermejo-Casares
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada E18016, Spain
| | - Ingrid Garzón
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada E18016, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada E18012, Spain
| | - María-Dolores Mesa-García
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada E18012, Spain; Department of Biochemistry and Molecular Biology II, School of Pharmacy, Campus Universitario de Cartuja, Granada 18071, Spain; Institute of Nutrition and Food Technology "José Mataix", Biomedical Research Center, University of Granada, Avenida del Conocimiento s/n, Granada 18100, Spain.
| | - Carolina Gómez-Llorente
- Instituto de Investigación Biosanitaria ibs.GRANADA, Granada E18012, Spain; Department of Biochemistry and Molecular Biology II, School of Pharmacy, Campus Universitario de Cartuja, Granada 18071, Spain; Institute of Nutrition and Food Technology "José Mataix", Biomedical Research Center, University of Granada, Avenida del Conocimiento s/n, Granada 18100, Spain.
| | - Miguel Alaminos
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada E18016, Spain; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada E18012, Spain.
| |
Collapse
|
5
|
Wood FM. The Role of Cell-Based Therapies in Acute Burn Wound Skin Repair: A Review. J Burn Care Res 2023; 44:S42-S47. [PMID: 36567469 DOI: 10.1093/jbcr/irac146] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
Tissue engineering solutions for skin have been developed over the last few decades with a focus initially on a two-layered structure with epithelial and dermal repair. An essential element of skin restoration is a source of cells capable of differentiating into the appropriate phenotype. The need to repair areas of skin when traditional techniques were not adequate addressed led to cell based therapies being developed initially as a laboratory-based tissue expansion opportunity, both as sheets of cultured epithelial autograft and in composite laboratory-based skin substitutes. The time to availability of the cell-based therapies has been solved in a number of ways, from using allograft cell-based solutions to the use of point of care skin cell harvesting for immediate clinical use. More recently pluripotential cells have been explored providing a readily available source of cells and cells which can express the broad range of phenotypes seen in the mature skin construct. The lessons learnt from the use of cell based techniques has driven the exploration of the use of 3D printing technology, with controlled accurate placement of the cells within a specific printed construct to optimise the phenotypic expression and tissue generation.
Collapse
Affiliation(s)
- Fiona M Wood
- University of Western Australia, Fiona Stanley Hospital, Perth Children's Hospital, Burns Service of WA, Level 4 Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch Western, Australia 6150
| |
Collapse
|
6
|
Optical Behavior of Human Skin Substitutes: Absorbance in the 200-400 nm UV Range. Biomedicines 2022; 10:biomedicines10071640. [PMID: 35884945 PMCID: PMC9313464 DOI: 10.3390/biomedicines10071640] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2022] [Revised: 07/05/2022] [Accepted: 07/06/2022] [Indexed: 11/25/2022] Open
Abstract
The most recent generation of bioengineered human skin allows for the efficient treatment of patients with severe skin defects. Despite UV sunlight can seriously affect human skin, the optical behavior in the UV range of skin models is still unexplored. In the present study, absorbance and transmittance of the UGRSKIN bioartificial skin substitute generated with human skin cells combined with fibrin-agarose biomaterials were evaluated for: UV-C (200−280 nm), -B (280−315 nm), and -A (315−400 nm) spectral range after 7, 14, 21 and 28 days of ex vivo development. The epidermis of the bioartificial skin substitute was able to mature and differentiate in a time-dependent manner, expressing relevant molecules able to absorb most of the incoming UV radiation. Absorbance spectral behavior of the skin substitutes showed similar patterns to control native skin (VAF > 99.4%), with values 0.85−0.90 times lower than control values at 7 and 14- days and 1.05−1.10 times the control values at 21- and 28-days. UV absorbance increased, and UV transmission decreased with culture time, and comparable results to the control were found at 21 and 28 days. These findings support the use of samples corresponding to 21 or 28 days of development for clinical purposes due to their higher histological similarities with native skin, but also because of their absorbance of UV radiation.
Collapse
|
7
|
Ortiz-Arrabal O, Chato-Astrain J, Crespo PV, Garzón I, Mesa-García MD, Alaminos M, Gómez-Llorente C. Biological Effects of Maslinic Acid on Human Epithelial Cells Used in Tissue Engineering. Front Bioeng Biotechnol 2022; 10:876734. [PMID: 35662841 PMCID: PMC9159156 DOI: 10.3389/fbioe.2022.876734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2022] [Accepted: 04/08/2022] [Indexed: 12/04/2022] Open
Abstract
In the present work, we evaluated the potential of maslinic acid (MA) to improve currently available keratinocyte culture methods for use in skin tissue engineering. Results showed that MA can increase cell proliferation and WST-1 activity of human keratinocytes after 24, 48, and 72 h, especially at the concentration of 5 μg/ml, without affecting cell viability. This effect was associated to a significant increase of KI-67 protein expression and upregulation of several genes associated to cell proliferation (PCNA) and differentiation (cytokeratins, intercellular junctions and basement membrane related genes). When human keratinocytes were isolated from skin biopsies, we found that MA at the concentration of 5 μg/ml significantly increased the efficiency of the explant and the cell dissociation methods. These results revealed the positive effects of MA to optimize human keratinocyte culture protocols for use in skin tissue engineering.
Collapse
Affiliation(s)
- Olimpia Ortiz-Arrabal
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada, Spain
- Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain
- Doctoral Program in Biochemistry and Molecular Biology, University of Granada, Granada, Spain
| | - Jesús Chato-Astrain
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada, Spain
- Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain
| | - Pascual Vicente Crespo
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada, Spain
- Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain
| | - Ingrid Garzón
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada, Spain
- Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain
| | - María Dolores Mesa-García
- Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain
- Department of Biochemistry and Molecular Biology II, School of Pharmacy, Campus Universitario de Cartuja, Granada, Spain
- Biomedical Research Center, Institute of Nutrition and Food Technology “José Mataix”, University of Granada, Granada, Spain
- *Correspondence: María Dolores Mesa-García, ; Miguel Alaminos,
| | - Miguel Alaminos
- Tissue Engineering Group, Department of Histology, Faculty of Medicine, University of Granada, Granada, Spain
- Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain
- *Correspondence: María Dolores Mesa-García, ; Miguel Alaminos,
| | - Carolina Gómez-Llorente
- Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain
- Department of Biochemistry and Molecular Biology II, School of Pharmacy, Campus Universitario de Cartuja, Granada, Spain
- Biomedical Research Center, Institute of Nutrition and Food Technology “José Mataix”, University of Granada, Granada, Spain
| |
Collapse
|